The estimated Net Worth of Elizabeth Mily is at least $1.74 millió dollars as of 1 April 2023. Ms. Mily owns over 6,346 units of Bristol-Myers Squibb Co stock worth over $1,743,069 and over the last 5 years she sold BMY stock worth over $0. In addition, she makes $0 as Executive Vice President - Strategy & Business Development at Bristol-Myers Squibb Co.
Elizabeth has made over 5 trades of the Bristol-Myers Squibb Co stock since 2021, according to the Form 4 filled with the SEC. Most recently she exercised 6,346 units of BMY stock worth $308,352 on 1 April 2023.
The largest trade she's ever made was exercising 29,636 units of Bristol-Myers Squibb Co stock on 10 March 2023 worth over $1,440,013. On average, Elizabeth trades about 7,526 units every 104 days since 2020. As of 1 April 2023 she still owns at least 35,873 units of Bristol-Myers Squibb Co stock.
You can see the complete history of Ms. Mily stock trades at the bottom of the page.
Elizabeth Mily has been appointed as Executive Vice President - Strategy & Business Development of the Company effective 3/30/2020. Mily joins Bristol Myers Squibb from Barclays, where she was the Managing Director and Chair of the Global Lifesciences group in the global healthcare unit. During her career she has executed over $200 billion in completed M&A advisory assignments and has advised on an extensive amount of debt, equity and equity-linked financings. Prior to joining Barclays, Mily served as Head of Corporate Strategy and Development at Thermo Fisher Scientific. Prior to that she spent 16 years at Goldman, Sachs & Co. where she was a Managing Director and senior coverage officer within the Healthcare Department of the Investment Banking Division.
Elizabeth's mailing address filed with the SEC is BRISTOL-MYERS SQUIBB COMPANY, 430 E. 29TH STREET, 14TH FLOOR, NEW YORK, NY, 10016.
Over the last 17 years, insiders at Bristol-Myers Squibb Co have traded over $318,151,721 worth of Bristol-Myers Squibb Co stock and bought 211,503 units worth $6,601,565 . The most active insiders traders include Lamberto Andreotti, James M Cornelius és Giovanni Caforio. On average, Bristol-Myers Squibb Co executives and independent directors trade stock every 8 days with the average trade being worth of $1,682,720. The most recent stock trade was executed by Cari Gallman on 1 August 2024, trading 1,061 units of BMY stock currently worth $51,554.
The Bristol-Myers Squibb Company is an American multinational pharmaceutical company. Headquartered in New York City, BMS is one of the worlds largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations. For fiscal 2022, it had a total revenue of $46.2 billion.
Bristol-Myers Squibb Co executives and other stock owners filed with the SEC include: